[Federal Register Volume 74, Number 62 (Thursday, April 2, 2009)]
[Notices]
[Pages 15066-15067]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7457]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under Public 
Law 92-463 (Federal Advisory Committee Act) that the Genomic Medicine 
Program Advisory Committee will meet on April 27, 2009, at the Madison 
Hotel, 1177 15th St NW., Washington, DC. The meeting will start at 8 
a.m. and end at 5 p.m.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care of Veterans and to enhance 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    The Committee will meet in an open session from 8 a.m. until 3:30 
p.m. to receive updates from the VA program staff; discuss optimal ways 
for VA to incorporate genomic information into its health care program 
while applying appropriate ethical oversight and protecting the privacy 
of Veterans; and receive an overview of the recent Institute of 
Medicine report on privacy protections in health research and 
discussions of potential areas of research in diseases/conditions 
prevalent in Veterans such as diabetes, women's health, specifically 
breast cancer, and the application of pharmacogenomics in clinical 
care.

[[Page 15067]]

    The Committee will meet in a closed session from 3:30 p.m. until 5 
p.m. for discussion of confidential and unpublished results of an 
ongoing pilot study. As provided by section 10(d) of Public Law 92-463, 
as amended, closing portions of this meeting is in accordance with the 
provisions set forth in sections 552b(c)(6) and (c)(9)(B), Title 5 
U.S.C., as amended. The discussions and review of the ongoing pilot 
study and related documents could disclose confidential information and 
therefore compromise this ongoing study.
    Public comments will be received at 3 p.m. Public comments will be 
limited to five minutes each. Individuals who speak are invited to 
submit 1-2 page summaries of their comments at the time of the meeting 
for inclusion in the official meeting record. Any member of the public 
seeking additional information should contact Dr. Sumitra Muralidhar, 
Designated Federal Officer, at [email protected].

    Dated: March 27, 2009.

    By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
 [FR Doc. E9-7457 Filed 4-1-09; 8:45 am]
BILLING CODE 8320-01-P